Rapport Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rapport Therapeutics Inc's ROI in the second quarter of 2026?
Rapport Therapeutics Inc recorded a cumulative net loss of $-137 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -28.51%.

Within the Healthcare sector 359 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3409, from total ROI ranking in the first quarter of 2026 at 4058.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	60.86 %	40.2 %	21.95 %	40.76 %	79.67 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	431	480	493	521	274
Return On Investment (TTM)	-28.51 %	-24.27 %	-28.21 %	-28.05 %	-29.52 %
RAPP's Overall Ranking	# 3409	# 4058	# 3574	# 3618	# 3577
Seq. Investment Change TTM	8.88 %	11.83 %	13.44 %	16.46 %	-5.11 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-137	-107	-111	-98	-88

RAPP Company Profile >> Back to RAPP Roi Comparisons >> See Annual RAPP Return On Investment

Return On Investment RAPP's Ranking
Within:	No.
Industry	# 139
Sector	# 360
Overall	# 3409

Return On Investment Statistics
High	Average	Low
-24.17 %	-26.86 %	-29.52 %
(Dec 31 2024)		(Jun 30 2025)

Financial Statements
Rapport Therapeutics Inc's II. Quarter Investments	$ 431 Millions	RAPP's Balance sheet
Rapport Therapeutics Inc's II. Quarter Income	$ -57 Millions	Quarterly RAPP's Income Statement
RAPP's Income by Division		See RAPP's Income by Division

RAPP Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	493	306	0	0	0
Y / Y Investment Growth	61.15 %	-	-	-	-
Net Income in Millions	-111	-78	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-22.6 %	-25.58 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RAPP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RAPP's Competitors
Subscribers only: Roi for Rapport Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for RAPP's Customers

Other Ratios
RAPP's Roa	RAPP's Inventory Turnover Ratio	RAPP's Growth Rates	RAPP's Dividend Statistics
	RAPP's Profitability Ratios	RAPP's Asset Turnover Ratio	RAPP's Dividend Growth
RAPP's Roe	RAPP's Valuation Ratios	RAPP's Financial Strength Ratios	RAPP's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-10T17:17:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.